Ultrasound-guided acupuncture for shoulder pain relief
Pragmatic Randomized Controlled Trial of Ultrasound Guiding Pharmacopuncture Therapy for Supraspinatus Tendinopathy: a Pilot Study
NA · Jaseng Medical Foundation · NCT06222710
This study is testing if using ultrasound to guide acupuncture can help people with shoulder pain feel better compared to regular acupuncture without ultrasound.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 19 Years to 69 Years |
| Sex | All |
| Sponsor | Jaseng Medical Foundation (other) |
| Drugs / interventions | radiation |
| Locations | 1 site (Daejeon) |
| Trial ID | NCT06222710 on ClinicalTrials.gov |
What this trial studies
This clinical study aims to evaluate the effectiveness of ultrasound-guided pharmacoacupuncture compared to traditional pharmacoacupuncture without ultrasound guidance in patients suffering from supraspinatus tendinopathy. It involves a randomized controlled design with 40 participants who have moderate to severe shoulder pain lasting over a month. The study will assess pain relief and treatment accuracy through imaging techniques. The goal is to determine if ultrasound guidance enhances treatment outcomes for this common shoulder condition.
Who should consider this trial
Good fit: Ideal candidates are adults aged 19 to 70 with confirmed supraspinatus tendinopathy and significant shoulder pain lasting more than one month.
Not a fit: Patients with serious shoulder injuries or other chronic conditions that may interfere with treatment outcomes are unlikely to benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide more effective pain relief and improved treatment outcomes for patients with shoulder tendinopathy.
How similar studies have performed: While similar approaches have been explored, this specific combination of ultrasound-guided pharmacoacupuncture is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Those between 19 and 70 years of age. * Those whose NRS (Numeric Rating Scale) of shoulder joint pain is 5 or higher and who complain of pain when abducting. * When supraspinatus tendinopathy is confirmed on MRI. * Those whose symptoms above last for more than 1 month. * Those who agree to participate in clinical research and provide written test subject consent. Exclusion Criteria: * For patients diagnosed with a specific serious disease that may cause shoulder pain (acute fracture, dislocation of the shoulder, complete rupture of rotator cuff, etc.) * For patients whose pain was caused by a condition other than the shoulder (tumor, fibromyalgia, rheumatoid arthritis, gout, cervical disc herniation, etc.) * In patients with other chronic conditions (such as stroke and myocardial infarction, kidney disease, diabetic neuropathy, dementia, epilepsy, etc.) that may interfere with treatment effectiveness or interpretation of outcomes * Patients currently taking steroids, immunosuppressants, mental illness drugs, or other drugs that may affect their findings * Inadequate or unsafe medication: hemorrhagic disease, anticoagulant therapy, severe diabetic patients with risk of infection * Patients who have taken drugs that can affect pain such as non-steroidal anti-inflammatory drugs (NSAIDs) within the last week or have experienced acupuncture treatment * For patients who have received steroid injections within the last 3 months * In the case of pregnant women and in the case of planning to become pregnant or nursing * For patients within 6 months of shoulder surgery * If it has not been one month since the end of participation in other clinical studies, or if you are planning to participate in other clinical studies within six months from the date of selection and participate in other clinical studies during the follow-up period * If it is difficult to fill out a consent form to participate in the study * In cases where it is difficult for other researchers to participate in clinical research
Where this trial is running
Daejeon
- Daejeon Jaseng Hospital of Korean Medicine — Daejeon, Korea, Republic of (RECRUITING)
Study contacts
- Principal investigator: Sunah Kim, KMD — Daejeon Jaseng Hospital of Korean Medicine
- Study coordinator: Sunah Kim, KMD
- Email: tnsdk2648@jaseng.org
- Phone: 82-42-1577-0007
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Pharmacological Action